GlassScriptPhysician profile
Vivian Shen
NPI 1336775295
$9,299.38
in general payments reported to CMS, 2019-2025
10 companies · $8,863 in 2025
The $8,863 reported for 2025 was more than what 89% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11.93 · 2023: $135 · 2024: $290 · 2025: $8,863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Travel and Lodging: $2,558 · Food and Beverage: $1,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Travel and Lodging | $2,557.77 |
| Food and Beverage | $1,729.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,990.99 | 2025 | Infinity |
| Boston Scientific Corporation | $1,425.33 | 2025 | Vercise, General - Dbs |
| Medtronic, INC. | $1,152.49 | 2024-2025 | Percept PC Brainsense |
| Neurocrine Biosciences, INC. | $290.17 | 2024-2025 | Ingrezza |
| Ipsen Biopharmaceuticals, INC | $146.02 | 2025 | Dysport |
| Acorda Therapeutics, INC | $135.00 | 2023 | Inbrija |
| Acadia Pharmaceuticals INC | $97.95 | 2025 | |
| Amneal Pharmaceuticals LLC | $24.86 | 2024 | Rytary |
| Abbvie INC. | $24.64 | 2024 | |
| Glaxosmithkline, LLC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivian Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.